<SEC-DOCUMENT>0001104659-23-004067.txt : 20230117
<SEC-HEADER>0001104659-23-004067.hdr.sgml : 20230117
<ACCEPTANCE-DATETIME>20230117081035
ACCESSION NUMBER:		0001104659-23-004067
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230117
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230117
DATE AS OF CHANGE:		20230117

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Theriva Biologics, Inc.
		CENTRAL INDEX KEY:			0000894158
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133808303
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12584
		FILM NUMBER:		23530317

	BUSINESS ADDRESS:	
		STREET 1:		9605 MEDICAL CENTER DRIVE
		STREET 2:		SUITE 270
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		(734) 332-7800

	MAIL ADDRESS:	
		STREET 1:		9605 MEDICAL CENTER DRIVE
		STREET 2:		SUITE 270
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Synthetic Biologics, Inc.
		DATE OF NAME CHANGE:	20120305

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADEONA PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20081027

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PIPEX PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20061214
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm233585d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:syn="http://syntheticbiologics.com/20230117">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_syn_syntheticbiologics.com_20230117 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20230117_20230117 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DEntityCentralIndexKey_0000894158 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-01-17to2023-01-17" name="dei:EntityCentralIndexKey">0000894158</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-17to2023-01-17" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="syn-20230117.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-01-17to2023-01-17">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894158</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-17</xbrli:startDate>
        <xbrli:endDate>2023-01-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_903_edei--DocumentType_c20230117__20230117_zDS5TlMDcnh2"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event
reported): <span id="xdx_90F_edei--DocumentPeriodEndDate_c20230117__20230117_ztourca58Qvh"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">January 17, 2023</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_909_edei--EntityRegistrantName_c20230117__20230117_zaFLjvjB844k"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" name="dei:EntityRegistrantName">THERIVA BIOLOGICS, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 32%; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20230117__20230117_zz51Q5QoTjT1"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="width: 1%; padding-right: 0.8pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 34%; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_900_edei--EntityFileNumber_c20230117__20230117_zKlOiJeRM5l"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" name="dei:EntityFileNumber">001-12584</ix:nonNumeric></span></b></span></td>
    <td style="width: 1%; padding-right: 0.8pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20230117__20230117_zSs5znMl28Jj"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" name="dei:EntityTaxIdentificationNumber">13-3808303</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction of</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">incorporation)</p></td>
    <td style="padding-right: 0.8pt; text-align: center">&#160;</td>
    <td style="padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt">(Commission File No.)</span></td>
    <td style="padding-right: 0.8pt; text-align: center">&#160;</td>
    <td style="padding-right: 0.8pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(IRS Employer Identification</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">No.)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_900_edei--EntityAddressAddressLine1_c20230117__20230117_zci2drAwt4Vi"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" name="dei:EntityAddressAddressLine1">9605 Medical Center Drive</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressAddressLine2_c20230117__20230117_zN5JbEhB1PI8"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" name="dei:EntityAddressAddressLine2">Suite 270</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_902_edei--EntityAddressCityOrTown_c20230117__20230117_zU90YHQb6xa"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" name="dei:EntityAddressCityOrTown">Rockville</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressStateOrProvince_c20230117__20230117_zA6AYmdCJI3c"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Maryland</ix:nonNumeric></span> <span id="xdx_90B_edei--EntityAddressPostalZipCode_c20230117__20230117_zCMyyZ5gE4lf"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" name="dei:EntityAddressPostalZipCode">20850</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices and zip
code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_903_edei--CityAreaCode_c20230117__20230117_z3WM6nv9sbdh"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" name="dei:CityAreaCode">301</ix:nonNumeric></span>) <span id="xdx_906_edei--LocalPhoneNumber_c20230117__20230117_zDgHWUj3fIYa"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" name="dei:LocalPhoneNumber">417-4364</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_904_edei--WrittenCommunications_c20230117__20230117_z61k9ee5Pwl"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_90A_edei--SolicitingMaterial_c20230117__20230117_zHhR9lGf05Sl"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_905_edei--PreCommencementTenderOffer_c20230117__20230117_zevsSJ1u17Ph"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_908_edei--PreCommencementIssuerTenderOffer_c20230117__20230117_zInyCntW0Wz2"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border: black 1pt solid; width: 33%; padding-left: 6.4pt; text-align: center"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 34%; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 33%; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>Name of each exchange on which<br />
 registered</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 6.4pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_909_edei--Security12bTitle_c20230117__20230117_zbN8lTUR1Aed"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" name="dei:Security12bTitle">Common stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_90E_edei--TradingSymbol_c20230117__20230117_zO041tGyJzm2"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" name="dei:TradingSymbol">TOVX</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_903_edei--SecurityExchangeName_c20230117__20230117_zgIpIkL3miG5"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NYSE American</ix:nonNumeric> </span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company&#160;<span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_90D_edei--EntityEmergingGrowthCompany_c20230117__20230117_zpbceGalKvSk"><ix:nonNumeric contextRef="From2023-01-17to2023-01-17" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by checkmark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 7.01.</b> <b>Regulation FD Disclosure.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 17, 2023, Theriva Biologics, Inc. (the
&#8220;Company&#8221;) issued a press release announcing that <span style="color: windowtext">the first patient had been dosed in VIRAGE,
the Phase 2b randomized, open-label, placebo-controlled, multicenter clinical trial of systemically administered VCN-01 in combination
with standard-of-care (SoC) chemotherapy as a first line therapy for patients with newly-diagnosed metastatic </span>pancreatic ductal
adenocarcinoma (PDAC).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The information in this
Item 7.01 and in the press release furnished as Exhibit 99.1 to this Current Report on Form 8-K shall not be deemed to be &#8220;filed&#8221;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section
or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended and shall not be incorporated by reference into any filing with
the U.S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless of any general
incorporation language in such filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The press release furnished
as Exhibit 99.1 to this Current Report on Form 8-K includes &#8220;safe harbor&#8221; language pursuant to the Private Securities Litigation
Reform Act of 1995, as amended, indicating that certain statements contained therein are &#8220;forward-looking&#8221; rather than historical.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 8.01. Other
Events.</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 17, 2023, the Company issued a press
release announcing that <span style="color: windowtext">the first patient had been dosed in VIRAGE, the Phase 2b randomized, open-label,
placebo-controlled, multicenter clinical trial of systemically administered VCN-01 in combination with standard-of-care (SoC) chemotherapy
as a first line therapy for patients with newly-diagnosed metastatic </span>pancreatic ductal adenocarcinoma (PDAC).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.45in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%; padding-right: 0.8pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)&#160;&#160;</span></td>
    <td style="width: 96%; padding-right: 0.8pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 0.8pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br />
Number</b></span></td>
    <td style="vertical-align: top; width: 1%; padding-right: 0.8pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 89%; padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><a href="tm233585d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.8pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.8pt"><a href="tm233585d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release issued by Theriva Biologics, Inc., dated January 17, 2023</span></a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="vertical-align: bottom; padding-right: 0.8pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: January 17, 2023</span></td>
    <td colspan="3" style="padding-right: 2.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THERIVA BIOLOGICS, INC.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%; padding-right: 0.8pt">&#160;</td>
    <td style="width: 3%; padding-right: 0.8pt">&#160;</td>
    <td style="width: 5%; padding-right: 0.8pt">&#160;</td>
    <td style="width: 42%; padding-right: 0.8pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt">&#160;</td>
    <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 1.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Steven A. Shallcross</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt">&#160;</td>
    <td style="padding-right: 0.8pt">&#160;</td>
    <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven A. Shallcross</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt">&#160;</td>
    <td style="padding-right: 0.8pt">&#160;</td>
    <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="padding-right: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LW4d6GSXDhVxyhgi3hYXpbg1I60/eyTf0m5DDIGQnPPlCDERG1rrGhnOyzKHIzZtrRxCiVdkNBf0jmy7S8HPEm/aOlbGDesPzMgz6JnZdKH8fXA+tcUqhWgeyiSMJURJKhMo9iLo9YzMVVdonFY1KFNBwdSyRqe4Gz8c1ZsMNd2QdEK2mkwKchqN8gfiSMZwoKd6Ed8t5HkmgslQgdgwPdo+5mEdNbCqsfFZdkT/HXwB5GpJJA== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm233585d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="tm233585d1_ex99-1img001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Theriva Biologics Announces First Patient Dosed
in VIRAGE, a Phase 2b Trial of Systemically Administered VCN-01 in Combination with Chemotherapy in Pancreatic Ductal Adenocarcinoma </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>-Initiation of Phase 2b trial follows clearance
from the US Food and Drug Administration (FDA) and Spanish Agency for Medicines and Health Products (AEMPS)- </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>-The first patient was dosed in Spain; trial
expected to enroll 92 adults at sites across the US, Spain, and Germany-</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: windowtext"><B>Rockville,
MD, January 17, 2023 &ndash;</B> Theriva Biologics (NYSE American: TOVX), (&ldquo;Theriva&rdquo; or the &ldquo;Company&rdquo;),</FONT>
a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need,
<FONT STYLE="color: windowtext">today announced the first patient has been dosed in VIRAGE, the Phase 2b randomized, open-label, placebo-controlled,
multicenter clinical trial of systemically administered VCN-01 in combination with standard-of-care (SoC) chemotherapy (gemcitabine/nab-paclitaxel)
as a first line therapy for patients with newly-diagnosed metastatic pancreatic ductal adenocarcinoma (PDAC). </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;The dosing of the first patient in our
Phase 2b PDAC trial represents an important step in our pursuit to address unmet needs for patients with difficult-to-treat cancers,&rdquo;
said Steven A. Shallcross, Chief Executive Officer of Theriva Biologics. &ldquo;The incidence of PDAC continues to rise and while it continues
to have one of the lowest survival rates among all cancer types, efforts to improve upon the standard of care treatment have largely stalled.
In contrast, we are encouraged by the growing clinical data that underscore VCN-01&rsquo;s differentiated mechanism of action, as well
as the biological activity and synergistic clinical benefit observed in combination with SoC chemotherapy for patients with PDAC and other
solid tumors. With regulatory clearance from the FDA and AEMPS, we look forward to the continued progress of this program and more broadly,
the advancement of our novel OV platform.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About VIRAGE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">VIRAGE is a two-arm Phase 2b open-label, randomized,
controlled, multicenter clinical trial in patients with histologically confirmed, newly-diagnosed metastatic PDAC. VIRAGE is expected
to enroll up to 92 adult participants at up to 25 sites across the US, Spain, and Germany. In both the control and treatment arms, patients
will receive gemcitabine/nab-paclitaxel standard of care chemotherapy over 28-day cycles. In the treatment arm only, patients will also
receive systemically administered VCN-01 seven-days prior to the first and fourth cycles of gemcitabine/nab-paclitaxel treatment. Primary
endpoints for the trial include overall survival and VCN-01 safety/tolerability. Additional endpoints include progression free survival,
objective response rate, and measures of biodistribution, VCN-01 replication, and immune response. Since this is an open label trial,
progress will be monitored very closely and steps to accelerate the clinical program may be implemented if supported by the emerging
data. More information about the trial is available <U>here</U> and through the Spanish Clinical Trials Registry (<U>EudraCT Number:
2022-000897-24</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Theriva Biologics, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Theriva Biologics (NYSE American: TOVX), is a
diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need.
The Company&rsquo;s subsidiary Theriva Biologics, S.L. , has been developing a new oncolytic adenovirus platform designed for intravenous
(IV), intravitreal and antitumoral delivery to trigger tumor cell death, improve access of co-administered cancer therapies to the tumor,
and promote a robust and sustained anti-tumor response by the patient&rsquo;s immune system. The Company&rsquo;s lead clinical-stage
candidates are: (1) VCN-01, an oncolytic adenovirus designed to replicate selectively and aggressively within tumor cells, and to degrade
the tumor stroma barrier that serves as a significant physical and immunosuppressive barrier to cancer treatment; (2) SYN-004 (ribaxamase)
which is designed to degrade certain commonly used IV beta-lactam antibiotics within the gastrointestinal (GI) tract to prevent microbiome
damage, thereby limiting overgrowth of pathogenic organisms such as VRE (vancomycin resistant Enterococci) and reducing the incidence
and severity of acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant (HCT) recipients); and (3) SYN-020,
a recombinant oral formulation of the enzyme intestinal alkaline phosphatase (IAP) produced under cGMP conditions and intended to treat
both local GI and systemic diseases. For more information, please visit Theriva Biologics&rsquo; website at <U>www.therivabio.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="tm233585d1_ex99-1img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified
by terminology such as &ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue,&rdquo; &ldquo;expects,&rdquo;
 &ldquo;anticipates,&rdquo; &ldquo;intends,&rdquo; &ldquo;plans,&rdquo; &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; and similar expressions,
and include statements regarding the trial being expected to enroll 92 adults at sites across the U.S., Spain and Germany and the continued
progress of the Company&rsquo;s program and more broadly, the advancement of our novel OV platform. These forward-looking statements are
based on management&rsquo;s expectations and assumptions as of the date of this press release and are subject to a number of risks and
uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and
assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ
materially from current expectations include, among others, the Company&rsquo;s and VCN&rsquo;s ability to reach clinical milestones when
anticipated including enrolling the expected number of patients in each trial, the Company&rsquo;s ability to successfully combine and
operate the business of the Theriva Biologics and VCN, the Company&rsquo;s and VCN&rsquo;s product candidates demonstrating safety and
effectiveness, as well as results that are consistent with prior results; the ability to complete clinical trials on time and achieve
the desired results and benefits, continuing clinical trial enrollment as expected; the ability to obtain regulatory approval for commercialization
of product candidates or to comply with ongoing regulatory requirements, regulatory limitations relating to the Company&rsquo;s and VCN&rsquo;s
ability to promote or commercialize their product candidates for the specific indications, acceptance of product candidates in the marketplace
and the successful development, marketing or sale of the Company&rsquo;s and VCN&rsquo;s products, developments by competitors that render
such products obsolete or non-competitive, the Company&rsquo;s and VCN&rsquo;s ability to maintain license agreements, the continued maintenance
and growth of the Company&rsquo;s and VCN&rsquo;s patent estate, the ability to continue to remain well financed, and other factors described
in the Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2021 and its other filings with the SEC, including subsequent
periodic reports on Forms 10-Q and current reports on Form 8-K. The information in this release is provided only as of the date of this
release, and Theriva Biologics undertakes no obligation to update any forward-looking statements contained in this release on account
of new information, future events, or otherwise, except as required by law.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>For further information, please contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chris Calabrese</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">LifeSci Advisors, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ccalabrese@lifesciadvisors.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">917-680-5608</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>syn-20230117.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaKCKbOdzZR+SYkxtmBwbakKryEpCHYr7SYS1T/2UX0F -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:syn="http://syntheticbiologics.com/20230117" elementFormDefault="qualified" targetNamespace="http://syntheticbiologics.com/20230117">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://syntheticbiologics.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="syn-20230117_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="syn-20230117_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>syn-20230117_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>syn-20230117_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://syntheticbiologics.com/role/Cover" xlink:href="syn-20230117.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://syntheticbiologics.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm233585d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm233585d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ] -\# 2(  A$! Q$!_\0
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M1VMK$WBR197BBMMA1MH^:?\ AZ5^WL?^"O$W[-7_  T!J ^"0_;I'PF7X?\
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M[//@&*1=.FU33M=AC^)'BFRB!B@TVW;39(AX'MD@"1-H.@265Z2',/CZ")A
MO@7[*_\ P3 _:G_:Z.G>/!8GP+\-?$5Q+?W_ ,5?B"]Y:S:Y9W)F>;5- T%R
M=3\2BZ=YV:ZLDL;"X=Y<^.'=V#?K&$X;XVAPSD=+QOXQH91D>21P.-H<'XK%
M4)YGC)T/85:<<=F#GB,3B,/'V,88##*IC,=0A6Q$:V)J.I#V?[EBLWP,\5C(
M\#Y%F&)SC,\%A:&;9P\*\+@<37J0J0Q<X8*I4E6A3FYU9T,0H4J-2,]%/D<E
M]F?\&_21?\+\^.R,JK'+\(]/FE 48:8^--%F,S <-*9B93(V6,A+EMQ+5_5^
M@5"81#(8]O+LP";3\IR"-NT@[2#P1P>YKX(_8M_8!^#'[$?A[5&\%7&L>*_'
MOBFWB@\6_$+Q$B6FJ:G81RI=IH^FZ/:J]MHNDQ7,$<O]B6^Z_6>/?+=RR)%C
M] BJ^6!M7&SI@8[]NE?SSXI\595QEQOF&=9+AXX#"6RO+Z=&EA*U.DL+A,//
M#QC3GC$Y2]JH<U1QFVFES0A>*/T[@W)J^19!ALMG.-&,*DZ\Z%.I2KU85L3)
MU*SJ[J"<]:<;)M<UV[:?S]_\'(YS_P $\[%-K%3^T#\+R68AE<QZ5XUDC/ P
M2DB)(AYVO&C@[E!'D/\ P;#EG_9$^/:%&F0_M(W%P4)ROVC_ (5E\.#]H8,"
M/-)@A/FD;R88OF_=ICV/_@Y' 7_@G?IJ@ +_ ,-!?#(X' S_ &-XXYP.,UX]
M_P &P@!_9$^/N0#_ ,9%S=0#_P TR^'U?J^$BW]%K,O>CS5./Y82%3ZMA_:0
M4GAY0E[3X[0Y)>Y%J+;6R<T>#5KXS_B).'PZQU=8:6 G>A[+#N+M3O;F]GS6
M=][W/Z6&7S>7CD4X +#;D@;MH)(!(&]\#@#<V,;CG_-;_:?^+E_\!?\ @K/\
M?OC3IFE6WB"^^$O[<OQ#^)>FZ%?2OIFFZEK/A/XV:UJ]A:RZA:_Z4[W-O%$A
M!W K%&F"B(%_TJMJY7Y5_P!7GH.NX\].M?YROQ*\#:)\2_\ @MYXL\ ^*[:*
M^\->,/\ @I+K?ASQ+8S017$%UH]W\=I+6YBDM9DDAFMKFTFEM+B&6-XY;>22
M"16B=D.OT8JN!HYWQQ7S7 T<WP&!X,Q7US!XJ,HQQ-+#XFK*II0E&_/#VBY)
MO1-J%IRYECXFK$?5^&J-.O\ Q.*,#24Y0BITG.I%)TY4TK:ZMRUT5NI])^)O
MC7_P7I_;EL%^+/@[1?VDM&^'UU ;KPY9_!?1]<^#?@^[TR5G<7OAAM+U?1)_
M&VCL=X34]4\4>--4 &R,A%P.A_8I_P""W/[9'[+WQ@\._!O]L35]=^(/PPMO
M'-MX/\=I\5=+O=.^+_PT>]OQIVLW*^([YY]9U2_\$29UCQ%X7\:W&IZG)H[$
MZ)J9C",O]UT5K:VULL%M;06\$,<L<,,$,<44,:+($2*.-52-%'"J@"J. !7\
M(W_!REX3T'0OV]?!FNZ38VEGJ'C#]F_P;JOBBYAM88+K6+FS\;_%#1+6ZNYX
MXTEO;FVT:QL=(MY[EI98=,LK33XV6UMHH4]KPSXNX8\4L;4X#SC@#A?(\I?#
M^/Q.5XW)L+[+,*.*R[+ZTHU<?B)TW*K)QC&<98:K!QJ\UXU(M<OG<1Y!B.&\
M#+.</G69U*D<\H5,33J5ZCHU(5YT4J<(N;22Y9*7.FI)I:6U_L@_:@_:C^&'
M[)7P/\9_M ?%7Q#%8>"_#UA!/I-O#<127OC#Q#J$8?POX*\/@PSK<>(?&6H,
MFE6*1":TL[=_[2N)+2TAFN5_CB\1?\%$_P#@L+_P4X\>:_X=_9-TKXA^"_ =
MI>P2VWA;X%FQ\*)X7L&5V@NO&GQGU;[/<27%VF\B:7QYX4\.>(PF_P +:9IY
M0,OT+_P76\<>(9_V#/\ @EKX=%Y.^D^.?AM'XR\1N[RM%<ZQHGP3^&=KHKWJ
M%F2YG>#QAJT,,MP))%CCF1&"R2 ^6?\ !/3_ (*@?M&_LE?LN>!_A)\(?^"<
MWC#XK^&TU'Q-K]Y\4-"A\?VLOQ%U/4/%.IS:GJTD?AKX>>*(9-1L[DRZ(+JY
MN)I$L](L[1<1VD*QOP_X%H9)P-C^/,LX;X<XMXJQ7$&-RG*X<6YIE66Y/A<)
MD^)Q&%=6GA\SQV#^M2J<T*E=4U/DO23=./O5,N*>(Z.9Y[1R[,\=C<KR7#X#
M"U:E3+,-BZ\ZM7%4XRDL4L)&4K+V:5*R:^-M-NZ\[NOVI_\ @N-_P2^U'2O$
M/QXD^*&K^"_$-S9V9TSX[ZMI7QU^'VH:O"I%I8Q?$/P]XIFN=)UK4PV9=*\-
M>--'TR8X9E8@&OZZ/V!OVW/!?[>?[.GA;XX>%K9/#&M?VA?^&?B+X#FO4N;[
MP1XWTJ2**\T*Z(:+[3;ZAIU[8ZOI-R&>.6UU;29@))4NTC_G6_:!_P""MW[5
MO[1_P:^(_P $?B!_P24\?:IX8^(G@_7O#ET^HV?Q2U3^S=1U'19+&UUS34OO
M@Q.MMJGA[4W6]TO4;<1WFGWD-O=6T\<\0>M+_@V\\+_M#_"KXO?M#?#GXA?"
MWXH>!/ ?B[X:Z'XTAG\=^"?$?A#3E\;>%?&$NB6MM9/JVD)#]JOO#WB6\FD,
M4JRRPV2*=ZQ!*7B-PIALWX!S;BGB'(N#N%.,<@J8+'PH\(<0Y'B\OXBPU6=-
M8C#T,#EN88VKAL3A5*%1*N^25Y*$IQYE#IX6Q=3#<01R_+,1F^:<.XW+L;5C
M6QU#$8;V=3"PBX^Q6,C&3_BM3<5%/W=+VO\ FMX$_P""PO[8?[._[6_C;Q?X
MY^,'Q.^,O@+P?XP^*^B:5\(?&'Q&U6V\(7VKWD7B#2O!MM??Z?-%-I6@W=]8
M2W%O+;M!:S6MM+&D<D$3I]D_L=?M!?\ !8;]KW]L;]G'XU?$"#]I&/\ 9QUC
MXI^$;_53X1\+>)_ '[/\/@*ZUG[;=6!@@L]+\/\ B_PU-9,EI<>(;S5?&5_-
M 5MY)PA&/RV_93^"FA?M$?\ !4SP7\)O%,$-QX:\1_M/>/-5\16-Q%%+;ZQX
M9\/^)-6\6Z[H=Q!.DD%RNK:7HDEIJ=O/%+%=VI,5S'-$-E?Z4=O8V5G':VMI
M9VMK;6L%O:6UO;6\4$%O:VT7EV]M!#$BQPV\$?R0PQJL<2?*BJO%>IXO9UP/
MP##*,GRG@#(\PXBS7AOEQ>>YC0QN#J97&67^PC7RJCA_9X7%5,7/'5YUZN*I
M3=.>#H2A-N2Y.;@G!YQGE7%XNMQ%FF7X;+,QQD,)A<OJ*#K1JU)<T<;*MSQJ
M1IJC"-)4U9*I537O(_BS_P""ZW[:_P"UM\"OVXU\!?!K]H;XI_#/PDWP9\!:
MFWA7PAXOU/2-..I7EUXA%YJ!L[:_MK=;V\$$)N+DIYLZQ0[G*)$J_3__  6I
M\8_MO?!OX1?LP_M2_ G]H/XO^#O 6N?#?P9X&^+.C^$?&NJ6VFZ=XWN_#]UK
M&A^,KZUMK^WM9U\2+?ZOI6I:A+$TEUJOAW08KB1Y;JU)_,K_ (..G=O^"BWE
MEF,?_"A_AD?++$IEM9\0H3M)VY*$H3C)4[3QQ7]=OQI_9UTO]JO_ ()Z:K\!
MKW[-'-\0OV=/#&G^&+F^C1XM+\;VGA[0-=\ :Q*TT<H3^Q_&>FZ1>S2(J216
MZN(WB9O,'EYIF&4\&\/_ $<^)*F0</XJOF& KT^(I5LJPDJ.-RK%XRE0KXK'
MPJ4*CQ57*X5G5P]>K&=:$FY<[5TNK"4<?FN/XWRZ>:XZ57#4\#5R_$57%?5O
M9?V@ZM-K#J$YNORTXQ=THJ+NKR/$O^".?[9.M_MI_L:^&/%_C/5XM4^*7P\U
M"]^&GQ+N)+R2XN=9U30K.UF\.>*9UN9IKR!O%7AF\T2^O+F<EKW7H-?EW/)Y
MY'T%_P %'_VHX_V/_P!C;XY?&^UO;>V\5:'X7?0?AXL\F#/\1O&$\'ACP>D5
MME3?1:=JFIIK]_""Q73=)OY]NV%C'_)7_P &_?[2S_LR_MI>._V<?B=/<^%]
M'^.]O<?#Z[T_5)9+--&^-OP\UJXM?#=M=VLS)"LNJ07_ (K\/([JLLFIG3H-
M_P JK7JO_!Q)^TUXB^,G[3GPS_8J^'6J:OJUA\,4T.?Q)X:TQY9D\3_&'XD6
MEFND:<T44I@O;_P_X=UWPAIVDRRQO<:?J'CG7%M6B:*[!\+,_"##4O'=9)EU
MX\#XS%4^.:.+J4ZLZ&+R&<(8_,</%T5[)493BL)ATN6G!2M5BHIHUP_%TL+P
M(\2I5L7FE#$?V3]4=2G]<JUJM7V$*T'*Z5.,.:K)2BYM*W-S,^G_ /@AI\5O
MV[OCMX2_:C_:3\<_&7XK?'.T^'O@ZZ\$?!#X<_$;QUK"^!?B#\3KC13XLN;B
M66XOKM+=]/MK3PWH45VUNQM+GQG=J9(OL+LGP7J?[5/_  7L_;^N]2UOX2Z%
M\:O"?@<ZOJ>GZ98?!?PL?@UX(L)HONZ7;^/-8FTW6]?,7\&J:EXR?R\D(ZBO
MZN?V5O@C\+/^";'[$?AKP=XFUG2]"\/_  L\&W/C3XN>-[UX(+;4O&6IQ?VY
MXV\122=9TEUNXDTK1+1U:>/3X-&TNU&VWM8C^(_C'_@Y.CU_QW<?#K]EC]C+
MQ)\4DN+IK3PS<ZSXQN=)\4^)'?.;V#X4^!_!WBS7K*SR23-J6IPESR<=*]'(
M<VQF>\;<;9_X>^%_"/$>38/'8?"\/8SB.MEF#R?)</@UBZ%>GBJ.(KX##8V>
M.=.&)3P[G5HI<U=\M2C&)F4,+EF7Y3EV=\4YOE5:=&MB\7#)<-7K5<0L6J$Z
M<*Z4*]:+POO0BTE"<I5.561^46M_M3?\%L?^":^OZ-J_QG\5_'+0-(\3W::3
MI>G?'2_M_C)\./$]X,.NEV?B/Q%=:U86.J, I_L7PUXNTOQ4Z$@ZB58@_P!A
MW_!-O]N#3?V^?V7?#/QNATNVT'Q?:ZQK?@/XE^%-/U">ZT_1?'GAY[*]N#8:
MDT2S#2]8\/:IH7BC2@>8K'Q##IDTDLMCO/\ +Y_P47_X*:?M;?M1_LI>-_A1
M\9O^"=OC#X+>"]1U#P5K#?%#7-)^)<%OX8O[?Q3IDML()/&W@3PZ;&;5;D0Z
M'=-"T1N;'5;FSDW0W4R2?>/_  :ZRRR?!/\ :GM)7>2"'XL>"9HX)'9X8YKC
MP=?)/,D3$HDLR6=HDSJH>1+:W5R1#&%]3Q8X;6<^&&*XUSKA'A3A3B[!YMA*
M,JO!V-R_%95C:&(G.E+FI8#&8N6'E3:C**JN,N;G<'.\E#SN%,UE1XDAEF6Y
M_G><Y;BZ<ITWGF&J8:6&^KIN4:$:D(5)>U=1*<G%)>SA[JO8_JDVJ3D@9'0X
M&1^/6OA[]O\ "C]DSXN1%?,E2#PQ>^5^^WF.U\<>';P+FVS* BP_NR,;$1%S
M@ 5]Q5S^J:)H>MZ;=Z;K.EZ?J^EW\:6]]8:G8VVH6=U$K)(D=S:744UO<1I)
M%'(J2HRJ\:,H5E4C^7\@S19'Q!D&=U*"Q%#)L[RK-JU-.,:DXY=C:6*]E2E-
M2A"I5C"4(3FN2,K.:<3]!XOR+_6?A?B3AR&)^K5\^X>SO)\/.2G*E&KF6 J8
M2%:M"FU4G3H3G&<HTVIN#FH-2:9_.=^P)^T3X"^ 7COQ:_Q#N=1TS3/&>B:)
MHMKJ\5H)K:RU+1]6F\^77XHB%TRU=YF8O9H\0WR93=)O7XH^.W_!*']HOQW\
M=M=\4?!"Y\$?$SX-_%SQ5KOC;3/BI:^*]+T[0_#^EZYJD^L76G>-[)KE;K25
M\+223R6IT>+Q4VOO/*LL2W9N((_V;^//_!,30=<%UKOP+UF#PK?F.8?\(GXC
MDN+OPW-$Q$YAL-01I+[P[YK_ #EKV/4$DFR6CC;K^4.L:5\9_A=J/B/X07P\
M=>'I=6NX;77_  3IM_=K;:WJ"0K%!=P6VEQKHNO6"6X$47FI.BP[8TPH"U_9
MV19GPUQ;GF.XTX-XPR_+,WS+"8>GQ)D_%>&Q&*P-*.'P?U7+L;##Y?B\#BJF
M.P%=XNK@Z]#&O!P<H0Q.'JN=E_GK@<W\1O ;(\)P#XC^',^*>$LMQ6:U,BXJ
MRFMBL-A*6)Q>8/%T\'4IU\/B\')X[VN&H\F9PCB7*C4>6R5ZK/8_"?[._P"P
M/^Q5;1'4(;;]M#X]PQ?9S#JZ65Q\,?#MP@4R+)H>GP2Z+!&0[K<RZE'XTN;>
M>W!NO^$8AF$B_<_[!_[1_P 6_C9\?_%$7C/7C_PC]C\--2DTGP7HUC)H_A30
M'7Q-X1C632]-C1'U1HXKFXAAUG4W;58X;F:U01P3,E>*? O_ ()G>//'%K;:
MY\8M5?X?>&97CO+7PKIT,%]XIN%*DQ&XENP;;0%!7&W5QJDB9 $8+*#^U'PC
M^"WPZ^"_AJV\+> O#=AHVG6\CS33!%N]6U&^D:.26^U75;A7O=1OY)(8I);J
M\FDE9HHB6W(N/S+Q%X@\/\'DV9Y-1S3,_$;C7'27UWB[-\4JBRQTY1<,-ET(
M>RH1PFM:G1HTL+[6G3A"%?&8IQ37ZMX6Y+XX\9\4Y+QOQ%AL+X8\&X:<Y99P
M9EF$IT<;G6"J)*.)SJ3J5,P;C3C1GAGF,H4'[>N\!1IQ=4]-F"R._FP1[!\@
MD9A&=BGA 20" "2!R.^!DU>/W%_W/\:;)%'*O[R..09^ZZ*X&<\X8$?@*LA0
M !@' QR!_G'M7\OP]M[.C"M.K.2K<]YJ"A%0;]V"C[^JDE>;Z+SO_:J48UZS
MC1H4^946YTU-5JCBIW]NW[CM>\.3767-K8_GX_X.2?\ E'AIO_9P/PR_],WC
M>O'_ /@V#_Y-$^/O_9Q<W_JL?A]7[R_M#?LU_!;]J3P&GPS^/O@*R^(_@>/6
M;+Q!%X<U+5/$&EVHU[3UN(]/O?M?AJ_TR^3[)%>744,QD!B2>0#B5@<;]FK]
MD[X!_LC>$-=\%?L^_#BP^&7ACQ#K[^*M;TC3M:\2ZS;7>O-:6MDUV;_Q1?:E
M?.OV*RM;0.)=OV:"& (L<$*)^PT..\!2\(,1X<O XIYA5XJCQ!',E5PWU)4?
M=3PSH/\ VOVR2O[1-T=4K7/F9</5I<64N(_K5!4*6&G0>%=.M[=N4%%252_L
M;76S5SZ3'5/^N8_]"-?YX<Y(_P""^MU@D9_X*=ZLAP2,I_POW[G'\/\ L]/:
MO]$+:I"\@$#';\NW?^M?GW_P[(_89/QN/[2C? /03\:3\2G^+)\?-XL\<->-
M\09/$G_"42>(CIY\4_\ ".'4)->^_8-IW]GL3Y;0F+Y*Y?"SCG!<"5N,:F/P
M&+QJXAX?Q>387ZK6PM+V-;%SK25>K]9?O4J2G%3C27M)-^[87%>05N(%D_L,
M31PW]FYUA,UJ>VA5G[6GAIQFZ-/V7PU)VM&4_<3^)6/OMO\ 5O\ 2?\ ]!DK
M^&7_ (.<% _;>^#G0X_9A\*A3UPI^)7Q9) ]%/4@<$DU_=$T8Q@#(.<@X[YS
M[<Y.?7/UKX<_:$_X)\_L>?M;>+])^('[1/P4T;XE>,-(\/1^$M*U74_$/C31
MKNR\/Q7MW>P:?';^&/%6EVAB@O-0U"[A/E%HKB^NI8FBDN)"WG>$W%>7< \7
M8;.LWPN)S'!TLGS? RPF!G0HXFM5QV#EAJ=2G4Q;]A&%!SYZJF^>45:G=FG%
MF3XKB#):F7X5TZ4ZV8X.M*=5MQA"G*=1WC!<\FU0<5RZ)SBWLS\OOVW?V#O%
M'[<W_!*3]E/3_A596E[\:OA!\(O@AXT\#Z9=SK;V_B:U/PR\/:!XW\"Q7L^P
MV#:E:6T&HV5S =KZAH5IY>Y[P/7XJ_\ !-7_ (+&?$/_ ()X:7-^RO\ M(?#
M+Q?KOPC\)>(O$9CTNRT>[L/BS\(9[C4'U/5](_L?65BTS7],^VW%[>:_X;O/
M^$7UC2+Z^NKO39;EII4D_N&\*^&]"\ ^&/#?@CPS9?V3X9\+:#HGA;PY8)-/
M)%INBZ1I*Z=I6EQRW<\DLD,%K;6MM"C2,(HK:&)R%2&OGO\ :,_84_8^_:UB
MEE^/GP*\"^/-6CCAC'B62QN_#OCJV6'"PVUKXZ\.77A_Q5%9H,)':KK"6RC&
M(E8Y'U_#'B7D.$R+,^$^.^%ZO%'!N89OC\RP,\+CH9=FW#ZQ5>M4J5L)B:^&
MK4I>T=2BJW(Z*E*GR^_2FXKQ\7D>*>/PN89!F.%R[-\-EV#HUL%BZ<<5A\RJ
MU,OH8JC1JPA>2E3ISJQA*UG><XVBER_AC^T1_P ',7P3T;P/+!^RK\)O'/CC
MXAZA S66J?%RQTOPEX!\.Q2$O)K5])X1U_Q7JGBZ .5W:=8R>$],FVM(WC*(
MD(/V7_X)S_M1>+OVP/V1_A7\;/'O@34O 'C'6[:]T_Q+I5_IEWI.DZW?:!/#
M97WB_P *6^I;;MO"'B&/;J>BF[BAF <J(@41Y/-?A5_P1V_X)O?!7Q';^-/"
M?[,GA'4_$.GG;97'Q#U[Q;\2[33[DJX%U8Z!\0_$GB3PHNKEL8U"33/MZ@ _
M:@,AOTF>.ULCI-E:QVUI:PJD<-M;R)90B**%88X;6S66,-'%&OEQQ;/*$8"(
M "0?G>*LT\-JF3X+(> ^#\UR^MA<?5Q>,S;.,WAF&+Q>"JX>4,/A:=*GAZ$*
M,*,U*O4<^=348RA)5/>EZ654>((599KGF:9;5J5L-B,)3P<94<!A,-4J2A2<
MJ-6O*,'*I.48<DI2J5JT:>'I*$ZB<?\ /?\ ^"9I8_\ !:7X58RS#]H'X^N@
M)/\ K'\/_%J%F'HSQQQQ.PY:-$0DJJ@?Z(I^^GU7_P!!K\Z_ W_!,K]AKX/_
M !7M/CY\./@-X?\ #7Q?TC5-;\0:3XS3Q7\0[V2SU[6HKM-;U5K'5/&4VEQ-
M<)J%]'<.+<;X[^[08-S-O^_VDG$*&.1&*A91(9P1*-G9F8[E/& ,+SD=371X
MM\>X'CW-N&<?@XYM2CE?"]'(\6\TE@9TJN8X1XW%XBI@E@5*5*@L/[&FXXNI
M*O*4(M1@O=)X3R:MP[E^,ABZE'$U\3C:^+A3P3=?$5,/6J35.M]73]K&DJDG
M1E-^ZL1"O24I.C*4OX)O^#CG_E(S_P!T&^&/_I\\0U_<O\$TC;X+_"=VQN?X
M6> ][X!8D^%-$!+$C+,=B@Y)R%4=ACY7_:*_X)T?L6_M/^/'^*?Q]^!FA?$#
MQZGA^S\/_P!N7WBWQSI-S_8-@SRV=H+;PWXBTBS<VTLTSVFV![B!IGDAE\R1
MF;[.T?1++0-,TG1M-7[-I&DV%CIVGV4-]*8+.TL+-;2TM8$>203VBV\4(C@Y
MCB"HJ;0N"^-N-<NXJX+\.,@P^#QF$K<&9'BLJQ^)KSHSHXZ.*>&Q3J82.':J
MTK>[!1Q-Y)^\G9\L(R;**^79YQ%F$J^"Q&&S&E@ZM.,,53IU81I5ZD,30Q=.
MHI/"58QQ4Y48U4_K<\-5H4E"K*!_#O\ \%^?V9KC]E_]M?P)^T[\)=)F\(Z'
M\:XO^%B0:WH5O'%:^'OCYX!\16D^NZW#);%5LK[74O/!?CFWAC>&ZNO%.J>*
M_$:#[?;3W59/_!'#X+?$/]O[_@I/K7[6GQET]_$^A?#OQ3K/QL\>>)7$D?A^
M?XG7%VC_  N\,:3:3B6!9/#^J3R:FEO&H^QZ?X&L!%Y,=S 5_LK_ &D_V5OV
M?/VK_!>D>"_VC?A]IWQ(\*^%M:_X2_1M+U75=>TU=)U^.SNM,BU*WO/#>IZ3
M>^=!8ZA>6;'SRK6MW<VTL<L5Q*M/_9U_95_9^_9*\+Z[X)_9^^'6F?#3PYXA
MUK_A+]<T_2K[6]3?4-<^SVMJES/J/B*^U.]\H6FG1VJ1/=>5'" L'E!_F_0,
M-XZO#^%G^K4LKQ3XSAEF(X=R[B*L\(Z=#(,1%P>7J23S!XI4)-*5.3@Y2INW
M-%S/!EP9#_6QYGA<5AUE-/"0SJI@:BG"I1E"O6C%SHN4J;IU8TO;4\0N6FG[
M7#SA&K0J7^5O^"Q'P6^)_P ?/^">GQY^'GP>T^_USQO>P^%M=A\,Z7E;SQ1H
M_A+QWX:\3>)O#D&\[9WU73]'NE@MW^6<HJ^6XPJ_S _\$0O^"B_[+W[#D?QC
M\!?M%:5J'@S6?&_B#3+WP[\6=,\(R>);ZRM+#18K*Z\!^++32+;6_&6C@ZE%
M]JDCT+P_XAM+FXEDGN=TZQNG]VBS*[JWWH3:K.) P>)P%."G4 @XP0.<C!^;
M-?G%\?O^"5_[ W[3_C&_\>_%G]GWPY>^-M0B;^U_$'AGQ+XN^'6H:RLC9EO_
M ! GP\US1;36=7#@R-J6K07.H.?F>ZV[2/CO#WCSAW*>#<V\/>,LGS?%Y#G%
M?^T)8SAVO0P&9X+'J4JE>-6MB<'72HSJ.,XN=3EC*FJ%2C5A6@Z7K\19-CYY
MSE_$V29C@:.84L/3C##8_$X:G@<3A\3%J$JE.JJU3$3IJF_9PPU)SY9U*GM(
MNG:?\_W_  5^_P""POP<_:Q_9[U;]F#]DRU\6_%#2_%5QI'B_P"*_P 0KSP=
MKFBZ;H?@;P?KPUV.WT?2M6A?Q59W U_0;"TUGQCJ'AY-!TG^SW.G17,FKP^7
M](?\&N?_ "1W]JP]_P#A:?@+_P!1#6*_:+X>?\$V?V)OA?\ "+QQ\%_!O[/G
M@G1?AY\2-+70?'T$FI^*KOQ!XOT6"6UN[73O$/CG4M4D\<R6MM=6=G<6UJOB
M'R+:XMX9;=(Y(PQ]6_9J_9$_9O\ V2]%\2:'^SA\,;/X7:7XNU.WUGQ-;Z3K
M'BC5X]4U*TA>VM+B:7Q;K&M%&MK>:2WMX[5XTAA=XUC12<]V:<><#1\-LS\/
M.#<AXEPN$KYIA<=1S7/L;@\17K1P]23D\;"&$PM:%:3CR4Z5.=;EI>RJU'%5
M8P.7+LCS2KQ5@,[SC-\%6QT\)7]O@\'2E]0I)QI\BRZM'D]O!IM5J\Z-*,JD
M/9P4I4YM?6-0&- I4G@]A^A'K['@ U/28'H/R%?ASC&5N:[2^RG:+[<RV=NE
MS] :=U*/*I*]I-7:OO:VNMEY:%18(T VH !]T< ?@.W'' QBL"?1-+O;FRN;
M[1])GU#3!)_9E]-8V=Q<60D4K(MI+*C3VHD3*N8"H9>&RN:ZHJI&"JD>A (_
M6HS! 6#F&(NH 5S&A90.  VW( ' P>*TISG3GS1G.BHIJ*P\Y4^925FJMN12
M5KJR=FI233O8RKT(8I1CBG'$4HOGE0Q%##XG#U*L&I4G.AB:56F^22YE4Y?;
M4W[U*49-LQU(NHY(9TB547&8YHMC*.%#JK':.2%W$!>GN-7 (.<<G)!'!/')
MP",\#MVI%LK-"Y2TMD,G^L*P1*9.<_/A!OYY^;//-6-J_P!T?D*BI&$J_MH1
MY%972LI2=DKRUE%V=^5+9/NRJ:JZU9PPU+$32A-8;VSH*G3;]BH>WM5349/F
MB[4XO^$E'=A"A<9SD]0 >F/?^O>I*3 ]!^0I:AQJ2G)N47'3D5GS+^9R>S;T
MM;:WH:VZOXG\3[VV_4:53=O*KNQMWD#=MSG;NQG&><9QF@(@8,$4,%V!@H#!
M,@[ 0,A<@':.,@'%.P#U&:*<5*_O2O;X;75M[WONNWS 84!YZ&F#RP=VW+8Q
MN(4G&=V,]<;OFQZ\]:FI-J^@_(4."DTYZ\OP\MU:^][NSV5AJW6_RM^I'O/H
M*I3;4=0558]\!' QO:3<&Z9R"#@]1VS6C@>@_(57=%. RJPSD;E! *D@'!SR
M.H/;-.4G33G&,&XQDHN:;:O9:6Z;776UA*/-.G>4U&,^=QB[<R4:D4GZ<]_D
M? _[;:SR:7^S_IR:5J7B&'5?CWX6L]0\,:=J#:1)XAM8]$UZY%K<:A'-;F.S
MADBBN9(I95C=XD8A6C5UP/V?9T\)_M%>-/ J:'XG^%>D:S\/M/U[P]\+/$>O
MVOB.&YFLM3=;_P 86=QH_B7QAH^FB5'AMKBRMO$@>8%3<1,Z$K]:_&#X/>%/
MBU:>'K3Q-/KMHWA;Q!;^*-"O?#NM7V@:CI^L6D4D$%U;WVGR17$4B0SR1+)$
M\<J([JCJ)'#8G@+X#^"/ OB>X\76L_B?Q%XRO=-;2/\ A+?&OBG6_%VOVFCK
M(DO]CZ??:Y>7CV&EF8),;&S$-N9$5BA-?>8;.,$^%,PRC$4J<Z^-X<SW+(2C
MAZDO99EF.8Y1C<%CN:4_9>PPE' XJC42IO'6Q,5A:L%&=_P['\,YU_K[1SC"
MXV:PE#B3A3-/8RQ#C?+LDX:S/(LPR]QO[U7,<1BL)BZ,KK#4X86<,5&=2=-K
M@OV>[^]N?B;^U4LEQ/<I:_%VQBM8)II)([6&3P=X>F,%LCL5@B>XN)YVCB"*
M9I)92N]V9O$?@W\'/"?QP^%B?%?XB:AK^M_$?XAWGB/4I/$T'B;Q5INI_#V6
M?6-7CLM*\(63:J%\,6V@6\<5NVGVXM(4^QR><C!8U@^Y?"7PV\-^#-5\9:[H
M:WL5_P#$+6T\4>(7N+M[A9-46SALT:W# >1 EM!# D(RJ1Q1HFU$51X=K'[,
M7PVU35O$)LKSQWX7T?Q)J>IW?BKPGX1^('BSPSX0\1W.KAWU>2_\.:+JEEID
M9U9KJX.IFS@MY+\SSM=R3-,Y(LYP->MF$\MIQRRL\1PQ6H8J6'=:K0PN59?+
M!YMA%&ARVGF&*]GC,-.[HQ='V.-C*%69U8_AS'T*&02S[#8;B?!X&MQ1#'9=
M7Q=7#4<1C<_JXB61X^E*4E:634:TJ5:-;FG[[Q>7>SQV'PDX^/\ P[^(?BSX
M@_L1^-_$'B:^EUG6]+\"?%;1[3Q= )M.?Q7IGA?2M973?$();S+:XU5K6$27
M"E9);B&&8L9CO/UQ\+93??"WX8RW :[N9_!'A26^GEF+3E[K1;&<W,L[DL\M
MPSL\TLA8R.[-(S,Y-:5Y\-/!LGP]U3X96FC6ND^#+O0;KPR^C:/%'IEM'I5_
M;2VE[%"EJD:1O=13R&XD5,SLQ,H<L^[S;PA\ ?#GP]U#3;[2_&WQ?U*'1[*'
M3[/1->^*?B_5_#0LK>%8+6V?P]>:A+I;0VD4<:6L?D!+=8XUA5!&H'+B\7E>
M,IYC#!TE@(SS[%9M@L-*A.M-T,9A:E"5%UZ,H4Z,H-TZDDTZ4O@@DE._K\/<
M.\79+CN'Z=5+.<=A.",OX?SC/L%FF&RVI+%8;.YYEAJJPV;T<74Q&%I9=.66
M45!1Q=25.KC,9.I6Q;:^=/A]X1T7]I'Q[\?]6^,%GJ&OIX,^)=]\+_"7@<ZQ
MK=KH_A?P[HFGQ,GB"'3[&^MH)M2\0275Y-;^)!:I=-';V2VET&MT">I_LY:E
MJVC6WQE\!QZUJ'B_1/A1\2M<\.^"]9U:\N]6U!M(D\/Z-XE_X1JXU749[BXU
M*YT/4=2OM(M[IY9'M[2V2U5ECMTC'<>)/@1X*\9>)=1\7VFH>./ _BO5[6UT
M?7M>\ ^./$7A*[\0V>GK,VG?V]'H=Y80:S<::MW<1Z;=:E'=W%C'-+';R)&^
MP>J?#SX:^$?AOH$'A?PIIHM--ADEU"62ZFFU'4;_ %.Z)6ZU;5=2OI)[W4]5
MN@";G4+R::YG+8=]HVU>;YI@9X/,O84Z4:F-PV4T<+A9X24(994RY8"GB*[K
M0?)76*I8?%4J2H<M1QQ4GC7.44SRLBX)XIRK-,!_:-+#X+&4,5Q?6SCB3#YE
M1S#%<683/*F=5LCPV*P$Z4*6%EP[7S'+,;[3$1J)8S I99[/#U*D3\T?AWX0
MTOXG? W3?C5\1O#/Q%^.7Q#\?:WK ED\(ZQ<V&J?#%+R?5S;:9X=L?$'C#PC
M9Z';:'<:=;VFI6V](X]>O7L'@.BADB]Y\#^-[KQG^PMXB\70^(O$'B*]A^%7
MQ-T__A*-:@TZQ\1:C/X:C\4:6=3G&E>(O$-B]XEW:'RID\33N[0I>236T[NB
M^B:[^R]\-)+SQ')H=WXZ\$Z3XAN]2N/$_A7P)X^\5>#_  CXAN]4MTBU.\O?
M#F@:G8:9#<ZE"1!J$UE!;27L0"7+RI\M>E:!\&? OAOX>W_P@T33YM/\#ZGI
M_C&PETV"ZF4P67BZYO+K6+6T?=FWA>77+HP1H L)CA< R)NKT<WSG*,6ZF+H
M4)N=;B/+\XP-"6'IT*>799A,/1IXG+9PI15"K6K.%&&'JX-4L/&A1OBH5*]1
MS7D9#PSQ)E^.IY?/')X7 \!YAPIF,GBZV)EF.<8^O.MA\XPM?%SGCJ6%6)>.
MQ^-PF/E4JPQN/JQRQTL*N1_,GQK\?>+?!7['OP\U?P]K-QHVK^*;+X5^&+_Q
MD#</<^'-+\6?V9;ZIXB,T;K/'<Q([N+HR"1993*7$F&&CXF_9\^&_P *K+P3
MXU\&^,K[X6^)-#\8>$8KKQ;?Z[XDUU/B-;3ZM'#>>%O%=E)J[_VE/XS1VM;&
M^FMKRXTEG0VWE(AAD^KKSX<>#;_P1;?#?5M$M-:\')I5KX=_L?6(TU*!K#3H
M8TL&<7:RAKBS:WBFM9ROF6TZ)+;M$Z*1XYX?_9C^'.DZCX<UG4]0\?\ C"'P
M]<V5YX7T#QI\0_%OBCPUX=O;%#+87MAHFM:I?6,EW8LH-E<WD5Q/:D!K>2-@
M",,-G6"6'H3=7$X&=#B+-\SQM+"X7#5UFN7YAA,50PF#3KJ5"-? 2K5(3IYA
M"KEU3#XFI5P]...H4)Q]''\$YM6SK#RJY9EV?0K\&Y+P_DN(QN:8K+\5PUF.
M38VEBLVS*EBL.Y8J-#.H?5G&65069TJN74J6)J2PF(JTY>?_ +46@>(?$GBK
MX4V&EZ)!\2M(TO\ X2;4O$_P7@\<0>"]2\707:Z7IVG:YY%]*ECJ>E>&+LW#
MW=A> 0+)>0^47G9E/0?LMWWAY+?XEZ/X;L/&F@IX=\7:>;WX7^,9;&ZNOA[J
M&H^%M#==*T>YTCQ#XJLFT.]LR=8@M[2]>T2ZO;J>.)7=YY?6_'WP:\&_%"70
MM1U9M?T/7/#HU!M#\1^$?$.J^&/$.G6NK"!]6TV/6-&N+.^?3-6DA@?5-/:;
M[)?O!"]Q"[QJU:7PQ^%OAOX;V^IVFAS:S>WVOW::OX@\0:_K6IZ[XAUF^M[.
MVTZV>\U?4KJXO6BM+*W@L[*W\XQ6EE$EI"JQ+BN"68X9\,X'+'BL16KX+!JA
M&G4HN,:=2>98W&UJ[K1O'$JM2Q%*/UBO;,5.FZ$YRPE+#1C[='A[/,#Q]B\X
MKRC3PF/Q=2O"G+$PQ525%9=@,%"E&LN2O2=*MA:TIT)Q6!4*D*V&@L55QLY?
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140115491202336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 17, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 17,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12584<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">THERIVA BIOLOGICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000894158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3808303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9605 Medical Center Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rockville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">417-4364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TOVX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>tm233585d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="syn-20230117.xsd" xlink:type="simple"/>
    <context id="From2023-01-17to2023-01-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894158</identifier>
        </entity>
        <period>
            <startDate>2023-01-17</startDate>
            <endDate>2023-01-17</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-01-17to2023-01-17">0000894158</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-01-17to2023-01-17">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-01-17to2023-01-17">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-01-17to2023-01-17">2023-01-17</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-01-17to2023-01-17">THERIVA BIOLOGICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-01-17to2023-01-17">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-01-17to2023-01-17">001-12584</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-01-17to2023-01-17">13-3808303</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-01-17to2023-01-17">9605 Medical Center Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-01-17to2023-01-17">Suite 270</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-01-17to2023-01-17">Rockville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-01-17to2023-01-17">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-01-17to2023-01-17">20850</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-01-17to2023-01-17">301</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-01-17to2023-01-17">417-4364</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-01-17to2023-01-17">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-01-17to2023-01-17">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-01-17to2023-01-17">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-01-17to2023-01-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-01-17to2023-01-17">Common stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-01-17to2023-01-17">TOVX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-01-17to2023-01-17">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-01-17to2023-01-17">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M ">DS<K<:/A60)P9C-26ZYYK0,J><(-#V,T^S#\1]AN35X1V+HCO^8W_AKM
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MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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M-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @
M44$Q5@=!36*!    L0   !               ( !     &1O8U!R;W!S+V%P
M<"YX;6Q02P$"% ,4    " !103%6JLGU$^T    K @  $0
M@ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !103%6F5R<(Q &
M  "<)P  $P              @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+
M 0(4 Q0    ( %%!,5:0=\=#: 0  "D1   8              " @0P(  !X
M;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !103%6GZ ;\+$"
M  #B#   #0              @ &J#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( %%!,5:7BKL<P    !,"   +              "  88/  !?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( %%!,5:JQ"(6,P$  "("   /              "
M 6\0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !103%6)!Z;HJT   #X
M 0  &@              @ '/$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    " !103%699!YDAD!  #/ P  $P              @ &T
L$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #^$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm233585d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://syntheticbiologics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm233585d1_8k.htm">tm233585d1_8k.htm</File>
    <File>syn-20230117.xsd</File>
    <File>syn-20230117_lab.xml</File>
    <File>syn-20230117_pre.xml</File>
    <File>tm233585d1_ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm233585d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2021q4": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "tm233585d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "syn-20230117_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "syn-20230117_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "syn-20230117.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "syn",
   "nsuri": "http://syntheticbiologics.com/20230117",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm233585d1_8k.htm",
      "contextRef": "From2023-01-17to2023-01-17",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://syntheticbiologics.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm233585d1_8k.htm",
      "contextRef": "From2023-01-17to2023-01-17",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001104659-23-004067-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-23-004067-xbrl.zip
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M6>F%F'^#5Q1'\:_%OH&L+XV:EVKJY5]02P,$%     @ 44$Q5O?]@G?_"@
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M(0Z!QV]4T/A)12$=5EXM\T;35TXW+,,BG\,N;"T4H'-+#V"S28TA"H@6NS.
MDDJ,"K6_2>'%ZA75P*MX9Q)82$CN>(IXIVECIKA5&Q WG0:A>>/EFB/[\7(1
MY7$Z9T;4NRZ2%_(99[CT!Y89DKN>P-EEVIRY:=,&A%&G07"N9A6CEJO!FBNO
MR]:(F1Q^K7C'T^>&ROWB-2V+[?5K*DE B-A\=:QB(Y#6>N-AL<:4?MJD"2,I
MW"D9*K<\6"TV>6A( N+!Y@O@(9<BK?7&P\6:B)7L[GX4_#5[+->0!<L'J-WR
MT6FYR8E5&A O7?X ;G0(*F+TLK_^ -KN%T O5H"$2VN1.D8'-&MPT]*%! UD
MKD4,)9&Z'G/-,W3/T9>4H.R1H(ORM7KUE>N+?'R^)26*U(2+8K3.8BQL&'6)
MG;\Q!33<>F]*2QD$3+WVX'>H5!%(AW@@YT:R+.KG>+F1>4;6X$R*_A!7% TU
MKUGJTP=!U$"3)E=Y6//$.P]$*M+WJDKU!?GA85]#Y'BT;#%H#)9KBB X 6U!
M0^7Z^PW\K>>W6=(DNJ0<PU=A&AK'J_BU[1D+^.T% 5'0=@4MVY<+4:[TQL G
MS)[$YCF+=K>"1X2HI[72JN7JNT8W,-HM-V\J4I.H0:$!L?86OP"%^RQ0+8\/
MM=[+]P4_]3"Z6F&.1T^+1RP/XLTF2U6/*LW!5\P[@QS?BAA0 ..&1$=$0/@-
ML G=G,@C41[Z 17!J!;M\;PMW:].2.)/NSOR0(2:TW!/MMDGN;.GCC./ ;&N
MS^H&%\<\R>L-# +$M[J%3@%35,\ +=5S9F46Z%>5"<ISL;VGO;[I2GZ2F_4F
M^6N)4R*W_!=02P,$%     @ 44$Q5DO6- 1;!P  U%@  !0   !S>6XM,C R
M,S Q,3=?<')E+GAM;,V<WW?:-A3'WW?._@>//0.!=.M"D_4D-/1PFC99H.VV
MEQYA"]")+#%)#O#?3[(QY8<E7UYZDX>$F"OI?C]7EGTMR9=O5RF/GJG23(JK
M1J=UUHBHB&7"Q.RJ\7G4O![UA\-&I T1">%2T*N&D(VW?_[\4V1_+G]I-J,!
MHSSI1>]DW!R*J7P3?2(I[47OJ:"*&*G>1%\(S]P1.6"<JJ@OTP6GAMHOBH9[
MT6^MSFL2-9N >K]0D4CU^7&XK7=NS$+WVNWE<MD2\IDLI7K2K5BFL I'AIA,
M;VL[6YUM?HKBEYR)IY[[-2&:1I:7T+V59E<-U^ZFV>5Y2ZI9NWMVUFG__?%N
M%,]I2II,.&XQ;92E7"U5Y3H7%Q?M_-O2],AR-5&\;..\7;JSK=E^RP+V.YYH
MUM.Y>W<R)B8/>VTSD=?"_=<LS9KN4+/3;9YW6BN=-$KX.4$E.7VDT\C]M=';
MMJK7PLRI8?&$22YG+,Y#UW9F[;ZT7=/ZG%<P5W1ZU;#FMIGN^5FG\]HU\NN>
MC5DO; _5S'6P1M3><V"AJ*;"Y)KO[(&](G1E;+^B25F1:_YT%PTSKMBF_W2B
MINML66I;M1\+RXU+I5-<QGM^<!<4>:"Y[. Y>DWCUDP^MQ/*; BZG?]>N8_-
MXF-.Q/[[+6_L>J*-(K$I:^-D0GG>QC=K<V#2_D&>E43&MM9JQ_8M#OW:#>.U
MBB.I$JHL\[(NHN*]X!WWV8U%>T&4K:@9SQG?QGVJ9.HCM*$A/8[NPK)-_#BB
MU]:'Q/DQX&16C?3 !,BT@P&U4@TFU7=4QXHM')L:N'N60,9=5,85VA!0E^?1
M(YTQY[-SQUV5J3L8'B,\18#PSS%'C:!:Q"A<"Y$1_D@74M7 W[<$,G^%R;Q*
M&R+JOS*B#%5\#:%]9 P$_ALF<(]"1.9C181FCA$$^K$UD/KOJ#<D'HV(V$=S
MRKG+_(@ ]?8J>R#ZUYCH_3I?"/S;9W?=MY<;./^=(L 0_/%20G"D%C$*#U0Q
MF=A+O0+P/S(&DK_ ).]1B,[\5B10XEM3<(Z$#_Q 'B+N =,QX857 WM,AY%7
MF$.QH^2FM3+1T?]#B0*#WS&&8D=)5VLD(D#O9TKM.10<8?S64.PHB6J=2 3N
MM\(PLW;3")^R=/+]P>L^[V,K*&>4Y-0G"HUO^61"&#=#$F)\: GEC)*3AL2A
ML>Y;38KPH4CHZ@-=AV ?F4)IH^2B07EHN!\42XE:CUA</X <VT*!HV2@88%H
MQ,=D-4RL,C9EQ7QC/7AO$2A_E/03)!<M#$,12[60.X^;^S*SY^:Z+Y/@$%]3
M$!H2E+ST!.EH@;E.$HM,;_[<,4$[H7!4FH/GFO""$)#Y@M!W3T/?A:-'R5=K
M9;X@].>GH3^'HT?)66ME8J/OVX_W:BR7GEEMKS$4.TK.6B,1&WI^];E7#TH^
MLV(Y5AWYHQ)0_(BI;%@L=@PV%W](KR\MH<P1T]IJ<=BL'Z0VA/_+%G5WF=7V
M4.Z("6Y(*,:#R2+^[B&';[G2@0F4,4I.6RD' ZN+M*+$WXWW+:!041+5*C$(
M3.^DFT.92Q%\EGML!66+DG'Z1&$,Q&Y)L_8. SM?@U?+H0RSAS(04'Y5S%@O
M^C)-,[%YKN.98?.80A&CI(E!>0BX1Y*SF!DF9A_M':1BA%>SKK*#@D9)"OW"
M$"@_*.HB3NVM>;YFS.U_4/?3J6\D#ME#J:/DA/5"\>D/M<ZH.C4&%:6@D4!)
M#Z&B,<8<&F=V&%QWNI.QV\7C&7&.K*"\45)#GR@$OI_D6!&WK7"T3B>2^[>J
M5!I"*:,D@@%I"*#W?*E&?& "A8N2 5;*01P?;E?QG(@9]:^,J+:$0D;)"$/B
M4,?B&6@LGITX%J-DACY1B'R+]>GV[+J?<#8C_AUNP0+@?3^8U -2,?86YMN0
MW"9TE>:^#.R':O0>4RATG"V<(7D8N+.$&9H4;@V8("*VJ==VSYTGDZ\O!0T"
MSAY/H&BT*8*OE/,/0B[%B!(M!4V*=" T2^ M HT$XIQDC5RT,'R1/+.D5+X
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M@?4;@2=M-G U;Q?ZM$9JJBUK'*^=)S9\AJ,'^H<PYQH*KG9PJX25)=X@>Y^
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M+3(P,C,P,3$W+GAS9%!+ 0(4 Q0    ( %%!,5;W_8)W_PH  &R'   4
M          "  6X#  !S>6XM,C R,S Q,3=?;&%B+GAM;%!+ 0(4 Q0    (
M %%!,59+UC0$6P<  -18   4              "  9\.  !S>6XM,C R,S Q
M,3=?<')E+GAM;%!+ 0(4 Q0    ( %%!,589 /QGX1,  .IO   1
M      "  2P6  !T;3(S,S4X-60Q7SAK+FAT;5!+ 0(4 Q0    ( %%!,58
M0OMC-0\  ! P   5              "  3PJ  !T;3(S,S4X-60Q7V5X.3DM
;,2YH=&U02P4&      4 !0!$ 0  I#D

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
